TrialBritish journal of cancer2013

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma.

T Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.